Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessa Koch

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Mental Health Clinician|December 7, 2023
Management of OFF condition in Parkinson diseaseJessa Koch
American Journal of Pharmaceutical Education|December 30, 2021
Teaching Intellectual Humility Is Essential in Preparing Collaborative Future PharmacistsIke de la Peña, Jessa Koch
Pharmacology & Therapeutics|May 27, 2020
VMAT2 inhibitors for the treatment of hyperkinetic movement disordersJessa Koch, Wei-Xing Shi, Khashayar Dashtipour
The Mental Health Clinician|June 30, 2018
Implementation and results of a symptom-triggered opioid withdrawal protocol at a Veterans Affairs medical centerJessa Koch, Sarah Ward, Christopher J Thomas
The International Journal of Pharmacy Practice|January 3, 2022
Student perception of academic advising in a school of pharmacyCaroline M Sierra, Jessa Koch, Jody Gonzalez, et al.
Frontiers in Public Health|June 23, 2023
The effect of the COVID-19 pandemic on the prescribing of opioid and opioid use disorder medications within an academic medical center in CaliforniaArmen K Fstkchian, Jessa Koch, Khaled Bahjri, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|March 18, 2024
Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic ReviewMohadese Golsorkhi, Jessa Koch, Farzin Pedouim, et al.
The Mental Health Clinician|June 30, 2018
Review of pharmacologic treatment in cluster A personality disordersJessa Koch, Taylor Modesitt, Melissa Palmer, et al.
American Journal of Physiology. Cell Physiology|June 19, 2009
Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayersShannon A Bainbridge, James M Roberts, Frauke von Versen-Höynck, et al.
Parkinsonism & Related Disorders|February 6, 2026
Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic reviewAva Baghaei, Ali Zare Dehnavi, Zahra Hashempour, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Mental Health Clinician|December 7, 2023
Management of OFF condition in Parkinson diseaseJessa Koch
American Journal of Pharmaceutical Education|December 30, 2021
Teaching Intellectual Humility Is Essential in Preparing Collaborative Future PharmacistsIke de la Peña, Jessa Koch
Pharmacology & Therapeutics|May 27, 2020
VMAT2 inhibitors for the treatment of hyperkinetic movement disordersJessa Koch, Wei-Xing Shi, Khashayar Dashtipour
The Mental Health Clinician|June 30, 2018
Implementation and results of a symptom-triggered opioid withdrawal protocol at a Veterans Affairs medical centerJessa Koch, Sarah Ward, Christopher J Thomas
The International Journal of Pharmacy Practice|January 3, 2022
Student perception of academic advising in a school of pharmacyCaroline M Sierra, Jessa Koch, Jody Gonzalez, et al.
Frontiers in Public Health|June 23, 2023
The effect of the COVID-19 pandemic on the prescribing of opioid and opioid use disorder medications within an academic medical center in CaliforniaArmen K Fstkchian, Jessa Koch, Khaled Bahjri, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|March 18, 2024
Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic ReviewMohadese Golsorkhi, Jessa Koch, Farzin Pedouim, et al.
The Mental Health Clinician|June 30, 2018
Review of pharmacologic treatment in cluster A personality disordersJessa Koch, Taylor Modesitt, Melissa Palmer, et al.
American Journal of Physiology. Cell Physiology|June 19, 2009
Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayersShannon A Bainbridge, James M Roberts, Frauke von Versen-Höynck, et al.
Parkinsonism & Related Disorders|February 6, 2026
Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic reviewAva Baghaei, Ali Zare Dehnavi, Zahra Hashempour, et al.
Pageof 1